Methylmethaqualone
Overview of the drug Methylmethaqualone
| Methylmethaqualone | |
|---|---|
| |
| INN | |
| Drug class | |
| Routes of administration | |
| Pregnancy category | |
| Bioavailability | |
| Metabolism | |
| Elimination half-life | |
| Excretion | |
| Legal status | |
| CAS Number | |
| PubChem | |
| DrugBank | |
| ChemSpider | |
| KEGG | |
Methylmethaqualone is a quinazolinone-class sedative and hypnotic drug that is structurally related to methaqualone. It was developed in the 1960s and has similar effects to methaqualone, including sedation, anxiolysis, and muscle relaxation.
Chemical structure and properties[edit]
Methylmethaqualone is a derivative of methaqualone, with a methyl group added to the nitrogen atom of the quinazolinone ring. This modification alters its pharmacokinetic properties, potentially affecting its potency and duration of action.
Pharmacology[edit]
Methylmethaqualone acts as a central nervous system depressant. It is believed to exert its effects by modulating GABA receptors, similar to other sedative-hypnotic drugs. This action results in increased inhibitory neurotransmission, leading to the drug's calming effects.
Medical use[edit]
Methylmethaqualone was initially developed for use as a sedative and hypnotic agent. However, due to concerns about its potential for abuse and addiction, its medical use has been limited. It is not commonly prescribed today and is considered a controlled substance in many countries.
Side effects[edit]
The side effects of methylmethaqualone are similar to those of other sedative-hypnotics and may include drowsiness, dizziness, nausea, and headache. In higher doses, it can cause more severe effects such as respiratory depression, hypotension, and coma.
Legal status[edit]
Due to its potential for abuse and addiction, methylmethaqualone is classified as a controlled substance in many jurisdictions. Its legal status varies by country, but it is generally subject to strict regulation.
Related compounds[edit]
Methylmethaqualone is chemically related to several other quinazolinone derivatives, including:
Related pages[edit]
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa
Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
